Akihito Tanaka

Dr. Akihito Tanaka

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2021 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
HMHikaru Morooka
Hikaru Morooka
ATAkihito Tanaka
Akihito Tanaka
DKDaisuke Kasugai
Daisuke Kasugai
MOMasayuki Ozaki
Masayuki Ozaki
ANAtsushi Numaguchi
Atsushi Numaguchi
SMShoichi Maruyama
Shoichi Maruyama

11 November 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
HMHikaru Morooka
Hikaru Morooka
DKDaisuke Kasugai
Daisuke Kasugai
ATAkihito Tanaka
Akihito Tanaka
MOMasayuki Ozaki
Masayuki Ozaki
ANAtsushi Numaguchi
Atsushi Numaguchi
SMShoichi Maruyama
Shoichi Maruyama
Acute kidney injury (AKI) is a major complication of sepsis that induces acid-base imbalances. While creatinine levels are the only indicator for assessing the prognosis of AKI, prognostic importance of metabolic acidosis is unknown. We conducted a retrospective observational study by analyzing a large China-based pediatric critical care database from 2010 to 2018. Participants were critically ill children with AKI admitted to intensive care units (ICUs). The study included 1505 children admitted to ICUs with AKI, including 827 males and 678 females. The median age at ICU admission was 22 months (interquartile range 7–65). After a median follow-up of 10.87 days, 4.3% (65 patients) died. After adjusting for confounding factors, hyperlactatemia, low pH, and low bicarbonate levels were independently associated with 28-day mortality (respective odds ratio: 3.06, 2.77, 2.09; p values: <0.01, <0.01, <0.01). The infection had no interaction with the three parameters. The AKI stage negatively interacted with bicarbonate and pH but not lactate. The current study shows that among children with AKI, hyperlactatemia, low pH, and hypobicarbonatemia are associated with 28-day mortality.

1 August 2021 in Journal of Infection
Verified
Journal Article
Open access
SYShohei Yamamoto
Shohei Yamamoto
ATAkihito Tanaka
Akihito Tanaka
YOYusuke Oshiro
Yusuke Oshiro
MIMasamichi Ishii
Masamichi Ishii
HIHironori Ishiwari
Hironori Ishiwari
NONorio Ohmagari
Norio Ohmagari

31 December 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
HMHikaru Morooka
Hikaru Morooka
ATAkihito Tanaka
Akihito Tanaka
DIDaijo Inaguma
Daijo Inaguma
SMShoichi Maruyama
Shoichi Maruyama
Objectives Patients with peripheral artery disease (PAD) are reported to have a poorer prognosis than those without PAD. PAD is sometimes found at dialysis initiation, but its influence on the prognosis in these patients has not been investigated. We aimed to compare the mortality rate between patients with PAD at the time of dialysis initiation and those without PAD. Design We undertook an observational prospective multicenter study of patients starting dialysis treatment. Data were collected on patients’ sex, age, presence of PAD, medication, medical history and clinical and laboratory data. Setting Seventeen centers participated in the Aichi Cohort Study of Prognosis in Patients Newly Initiated into Dialysis. Participants A total of 1524 patients with chronic kidney disease started dialysis from October 2011 to September 2013. The patients were followed-up until March 2015. During this time, there were two patients who lost the follow-up. Primary and secondary outcome measures The primary outcome was defined as all-cause mortality. The secondary outcomes were defined as each cause of mortality. Results This study included 1030 men and 492 women with a mean age of 67.50±13.10 years. Of these, 71 had PAD and 1451 did not have PAD. After a median follow-up of 814.5 days, 33.80% of the former group and 17.00% of the latter group had died in March 2015 (p=0.001). After adjusting for confounding factors, PAD at dialysis initiation remained an independent risk factor for mortality (p<0.01). Conclusions Patients with PAD at the time of dialysis initiation had a poorer prognosis than patients without PAD. Therefore, the presence of PAD in patients starting dialysis should be considered for their monitoring and follow-up.

4 July 2017 in Acta Cardiologica
Verified
Journal Article
Closed access
ATAkihito Tanaka
Akihito Tanaka
DIDaijo Inaguma
Daijo Inaguma
EIEri Ito
Eri Ito
NKNaoki Kamegai
Naoki Kamegai
AKAkiko Kato
Akiko Kato
ATAsami Takeda
Asami Takeda
Background In patients with chronic kidney disease (CKD), prevalence of sleep apnoea syndrome (SAS) is reported to be markedly high. However, the factors associated with severity of SAS in such patients rarely have been reported. Methods This was a cross-sectional study of 100 stable non-dialysis patients with CKD who attended a CKD educational programme from April 2014 to August 2015. Diagnosis of SAS and its severity were assessed using a type-3 portable monitor. Results Eighty-six men and 14 women with a mean age of 71.6 ± 9.7 years were included. Mean apnoea-hypopnoea index (AHI) was 26.0 ± 13.8. Severe SAS was seen in 39 patients. Significant differences in brain natriuretic peptide (BNP) level (213.6 ± 329.6 pg/mL vs 107.8 ± 141.3 pg/mL, P < 0.05) and cardiothoracic ratio (CTR, 52.4% ± 6.3% vs 49.6% ± 5.7%, P < 0.05) were seen between patients with and without severe SAS. After adjusting for various parameters, BNP level, CTR, and diameter of the inferior vena cava at the end of inhalation were found to correlate with AHI. Conclusions In patients with CKD, prevalence of severe SAS is extremely high. In these patients, fluid retention, rather than systolic or diastolic function, correlates with severity of SAS.

1 January 2011 in Internal Medicine
Verified
Journal Article
Open access
PDF file
ATAkihito Tanaka
Akihito Tanaka
ITIkuko Tsujimoto
Ikuko Tsujimoto
YIYukiko Ito
Yukiko Ito
YSYasuhiro Sugiura
Yasuhiro Sugiura
NUNobuko Ujihira
Nobuko Ujihira
RSRyozo Sezaki
Ryozo Sezaki
An 81-year-old man was hospitalized because of fever and pain in the temporal region. Temporal artery biopsy revealed temporal arteritis; steroid therapy was started. Chest computed tomography and kidney biopsy revealed interstitial pneumonia and necrotizing crescentic glomerulonephritis, respectively. Because his myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) level was 215.0 U/mL, a diagnosis of microscopic polyangitis (MPA) was made. The patient was discharged after reduction of the steroid dose. However, his respiratory symptoms exacerbated, necessitating rehospitalization. He died 1 week later due to respiratory failure. MPA rarely involves the temporal artery. In the cases of large vessel lesions, ruling out MPA is important.